High materiality7/10
BTIG Raises Rapport Therapeutics Price Target to $89
Why it may matterVerify against the original reporting
Bullish analyst outlook, tempered by the uncertainty of a single firm's target forecast.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BTIG raised its price target for RAPP to $89, versus the posted price of $29.79, implying substantial analyst-forecast upside. A price target is an opinion, not a guarantee.
- BTIG price target: $89; posted price: $29.79.
- The target implies roughly 199% upside from the posted price.
Key facts
- 01
Target: $89
- 02
Posted price: $29.79
- 03
Analyst firm: BTIG
- 04
Analyst: Kambiz Yazdi
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.